COVID-19-infected patients have been shown to develop significantly more thrombotic complications and to have increased von Willebrand factor (VWF) activity, VWF antigen, and FVIII activity levels, as well as elevated D-dimer and fibrinogen levels, compared with non-COVID-19-infected patients [51]. The gene discussed is VWF; the disease is COVID-19.